FCG ADVISORS, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 937 filers reported holding NOVARTIS A G in Q3 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.5%.

Quarter-by-quarter ownership
FCG ADVISORS, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2020$507,000
-3.8%
5,832
-3.3%
0.12%
-13.1%
Q2 2020$527,000
+3.7%
6,034
-2.0%
0.14%
-5.5%
Q1 2020$508,000
-5.2%
6,159
+8.9%
0.14%
-5.8%
Q4 2019$536,000
+7.0%
5,658
-1.8%
0.15%
+0.7%
Q3 2019$501,000
-2.9%
5,762
+2.0%
0.15%
-6.1%
Q2 2019$516,000
-4.6%
5,651
+0.5%
0.16%
-8.9%
Q1 2019$541,000
+9.1%
5,624
-2.7%
0.18%
-5.3%
Q4 2018$496,000
+2.1%
5,781
+2.4%
0.19%
+13.2%
Q3 2018$486,000
+14.1%
5,6430.0%0.17%
+8.4%
Q2 2018$426,000
+21.0%
5,643
+29.5%
0.15%
+26.2%
Q1 2018$352,000
-3.6%
4,359
-0.7%
0.12%
-10.3%
Q4 2017$365,000
+0.8%
4,391
+2.8%
0.14%
+1.5%
Q3 2017$362,000
+1.4%
4,2710.0%0.13%
+11.7%
Q2 2017$357,000
+14.1%
4,271
+0.3%
0.12%
-4.8%
Q1 2017$313,000
-2.5%
4,259
-3.2%
0.13%
-12.5%
Q4 2016$321,000
-13.9%
4,402
-6.9%
0.14%
+25.2%
Q3 2016$373,000
-6.3%
4,730
-1.8%
0.12%
-8.0%
Q2 2016$398,000
+88.6%
4,819
+125.0%
0.12%
-24.7%
Q2 2015$211,000
-13.5%
2,142
-13.6%
0.17%
+32.8%
Q1 2015$244,000
-16.4%
2,479
-19.2%
0.12%
-13.2%
Q4 2014$292,000
+38.4%
3,069
+13.0%
0.14%
+3.6%
Q3 2014$211,000
-24.4%
2,716
-12.0%
0.14%
-34.1%
Q2 2014$279,000
+16.2%
3,086
+9.3%
0.21%
+24.1%
Q1 2014$240,000
+3.4%
2,824
-2.3%
0.17%
+9.0%
Q4 2013$232,0002,8900.16%
Other shareholders
NOVARTIS A G shareholders Q3 2017
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders